Milestone Pharmaceuticals Statistics
Total Valuation
MIST has a market cap or net worth of $178.78 million. The enterprise value is $153.41 million.
Important Dates
The next estimated earnings date is Thursday, March 12, 2026, before market open.
| Earnings Date | Mar 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
MIST has 101.58 million shares outstanding. The number of shares has increased by 31.08% in one year.
| Current Share Class | 85.17M |
| Shares Outstanding | 101.58M |
| Shares Change (YoY) | +31.08% |
| Shares Change (QoQ) | +45.37% |
| Owned by Insiders (%) | 1.14% |
| Owned by Institutions (%) | 31.05% |
| Float | 77.03M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 8.72 |
| P/TBV Ratio | 8.72 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 8.24, with a Debt / Equity ratio of 2.79.
| Current Ratio | 8.24 |
| Quick Ratio | 7.98 |
| Debt / Equity | 2.79 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -15.17 |
Financial Efficiency
Return on equity (ROE) is -260.65% and return on invested capital (ROIC) is -45.94%.
| Return on Equity (ROE) | -260.65% |
| Return on Assets (ROA) | -41.97% |
| Return on Invested Capital (ROIC) | -45.94% |
| Return on Capital Employed (ROCE) | -74.11% |
| Weighted Average Cost of Capital (WACC) | 6.41% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.76M |
| Employee Count | 33 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -14.98% in the last 52 weeks. The beta is 0.46, so MIST's price volatility has been lower than the market average.
| Beta (5Y) | 0.46 |
| 52-Week Price Change | -14.98% |
| 50-Day Moving Average | 2.18 |
| 200-Day Moving Average | 1.85 |
| Relative Strength Index (RSI) | 35.62 |
| Average Volume (20 Days) | 2,803,816 |
Short Selling Information
The latest short interest is 9.39 million, so 9.24% of the outstanding shares have been sold short.
| Short Interest | 9.39M |
| Short Previous Month | 8.25M |
| Short % of Shares Out | 9.24% |
| Short % of Float | 12.19% |
| Short Ratio (days to cover) | 1.14 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -57.23M |
| Pretax Income | -58.01M |
| Net Income | -58.01M |
| EBITDA | -57.13M |
| EBIT | -57.23M |
| Earnings Per Share (EPS) | -$0.78 |
Full Income Statement Balance Sheet
The company has $82.59 million in cash and $57.21 million in debt, with a net cash position of $25.38 million or $0.25 per share.
| Cash & Cash Equivalents | 82.59M |
| Total Debt | 57.21M |
| Net Cash | 25.38M |
| Net Cash Per Share | $0.25 |
| Equity (Book Value) | 20.50M |
| Book Value Per Share | 0.20 |
| Working Capital | 76.15M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$43.11 million and capital expenditures -$41,000, giving a free cash flow of -$43.15 million.
| Operating Cash Flow | -43.11M |
| Capital Expenditures | -41,000 |
| Free Cash Flow | -43.15M |
| FCF Per Share | -$0.42 |
Full Cash Flow Statement Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
MIST does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -31.08% |
| Shareholder Yield | -31.08% |
| Earnings Yield | -32.45% |
| FCF Yield | -24.14% |
Analyst Forecast
The average price target for MIST is $8.50, which is 382.96% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $8.50 |
| Price Target Difference | 382.96% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |